AVADEL PHARMACEUTICALS PLC (NASDAQ:AVDL) Files An 8-K Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.

AVADEL PHARMACEUTICALS PLC Exhibit
EX-99.1 2 tv486008_ex99-1.htm EXHIBIT 99.1   Exhibit 99.1   BUSINESS OF AVADEL   General Overview   Avadel Pharmaceuticals plc (“Avadel”) is a branded specialty pharmaceutical company. Avadel’s current revenues are primarily derived from products it markets based on first-to-file New Drug Applications (“NDAs”) for pharmaceutical products previously sold in the U.S. without Food and Drug Administration (“FDA”) approval (“Unapproved Marketed Products” or “UMDs”). In addition,…
To view the full exhibit click here